CompoAtlas

KATINKO

Natural health product licensed in Canada

Licence holder
Greenstone Pharmaceutical, Inc.
NPN or DIN-HM
80142531
Status
Active licence
Licence date
9 July 2025
Revision date
Not provided
Form
Onguent
Route of administration
Topique
Application type
Officinale

Oral dose analysis does not apply without an established exclusively oral route.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the source
2-hydroxybenzoate de méthyle

Source : Salicylate de méthyle

13 %
dl-Camphre

Source : dl-Camphre

11 %
(1R,2S,5R)-5-méthyl-2-(propan-2-yl)cyclohexan-1-ol

Source : l-Menthol

7.6 %

Non-medicinal ingredients

Vaseline blanche, C.I. n° 75810

PopulationAgeQuantity per servingFrequency
Enfants, adolescents et adultesminimum: 3 yearsNot specifiedNot specified

Uses authorised in Canada

Text supplied in English because no French text is available.

Temporarily relieves aches and pains/soreness of muscles and joints (associated with one or more of the following: simple backache, lumbago, strains and sprains (involving muscles, tendons, and/or ligaments), and arthritis).

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

No French warning text available in the imported data.

Warnings are available in English on the official record.

Source

Official Health Canada record, licence 80142531

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Enter to analyse, Shift+Enter for a new line